Skip to main content

Advertisement

SpringerLink
Log in

Neuromyelitis optica spectrum disorder complicated with Sjögren’s syndrome: first pediatric case responsive to mycophenolate mofetil treatment

  • Letter to the Editor
  • Published:
Acta Neurologica Belgica Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Kornitzer JM, Kimura Y, Janow GL (2016) Primary Sjogren syndrome in a child with a neuromyelitis optica spectrum disorder. J Rheumatol 43(6):1260–1261. https://doi.org/10.3899/jrheum.151207

    Article  PubMed  Google Scholar 

  2. Shiboski CH, Shiboski SC, Seror R et al (2017) 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjogren’s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Ann Rheum Dis 76(1):9–16. https://doi.org/10.1136/annrheumdis-2016-210571

    Article  PubMed  Google Scholar 

  3. Wingerchuk DM, Banwell B, Bennett JL et al (2015) International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85(2):177–189. https://doi.org/10.1212/WNL.0000000000001729

    Article  PubMed  PubMed Central  Google Scholar 

  4. Birnbaum J, Atri NM, Baer AN et al (2017) Relationship between neuromyelitis optica spectrum disorder and Sjogren’s syndrome: central nervous system extraglandular disease or unrelated, co-occurring autoimmunity? Arthritis Care Res (Hoboken) 69(7):1069–1075. https://doi.org/10.1002/acr.23107

    Article  CAS  Google Scholar 

  5. Sawada J, Orimoto R, Misu T et al (2014) A case of pathology-proven neuromyelitis optica spectrum disorder with Sjogren syndrome manifesting aphasia and apraxia due to a localized cerebral white matter lesion. Mult Scler 20(10):1413–1416. https://doi.org/10.1177/1352458514540834

    Article  PubMed  Google Scholar 

  6. McKeon A, Lennon VA, Lotze T et al (2008) CNS aquaporin-4 autoimmunity in children. Neurology 71(2):93–100. https://doi.org/10.1212/01.wnl.0000314832.24682.c6

    Article  PubMed  CAS  Google Scholar 

  7. Bulut E, Karakaya J, Salama S et al (2019) Brain MRI findings in pediatric-onset neuromyelitis optica spectrum disorder: challenges in differentiation from acute disseminated encephalomyelitis. AJNR Am J Neuroradiol 40(4):726–731. https://doi.org/10.3174/ajnr.A6003

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  8. Zhou Y, Zhong X, Shu Y et al (2019) Clinical course, treatment responses and outcomes in Chinese paediatric neuromyelitis optica spectrum disorder. Mult Scler Relat Disord 28:213–220. https://doi.org/10.1016/j.msard.2018.12.038

    Article  PubMed  Google Scholar 

  9. Shahmohammadi S, Doosti R, Shahmohammadi A et al (2019) Autoimmune diseases associated with neuromyelitis optica spectrum disorders: a literature review. Mult Scler Relat Disord 27:350–363. https://doi.org/10.1016/j.msard.2018.11.008

    Article  PubMed  Google Scholar 

  10. Longoni G, Banwell B, Filippi M et al (2014) Rituximab as a first-line preventive treatment in pediatric NMOSDs: preliminary results in 5 children. Neurol Neuroimmunol Neuroinflamm 1(4):e46. https://doi.org/10.1212/NXI.0000000000000046

    Article  PubMed  PubMed Central  Google Scholar 

  11. Marino A, Narula S, Lerman MA (2017) First pediatric patient with neuromyelitis optica and Sjogren syndrome successfully treated with tocilizumab. Pediatr Neurol 73:e5–e6. https://doi.org/10.1016/j.pediatrneurol.2017.05.015

    Article  PubMed  Google Scholar 

Download references

Funding

The authors received no financial support for the research, authorship, and/or publication of this article.

Author information

Author notes

  1. Gao-Li Fang and Wei Fang have contributed equally to this work.

Authors and Affiliations

  1. Department of Neurology, Zhejiang Chinese Medicine and Western Medicine Integrated Hospital, Hangzhou, China

    Gao-Li Fang

  2. Department of Neurology, Fourth Affiliated Hospital, School of Medicine, Zhejiang University, Yiwu, China

    Wei Fang

  3. Department of Neurology, Second Affiliated Hospital, Zhejiang University, 88 Jiefang Road, Hangzhou, 310009, China

    Yang Zheng & Yin-Xi Zhang

Authors
  1. Gao-Li Fang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wei Fang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yang Zheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yin-Xi Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yin-Xi Zhang.

Ethics declarations

Conflict of interest

The authors have no conflicts of interest to declare.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fang, GL., Fang, W., Zheng, Y. et al. Neuromyelitis optica spectrum disorder complicated with Sjögren’s syndrome: first pediatric case responsive to mycophenolate mofetil treatment. Acta Neurol Belg 121, 1065–1067 (2021). https://doi.org/10.1007/s13760-020-01530-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13760-020-01530-z

Keywords

Search

Navigation